In this article, we discuss the Best Defensive Stocks to Invest In Now.
The US economy has entered the final week of April navigating a precarious war-driven landscape that has fundamentally altered the outlook for both growth and monetary policy. According to a Reuters report from earlier this month, the primary engine of uncertainty is the escalating conflict in the Middle East, which has triggered an energy shock exceeding the disruptions seen in the 1970s. A Reuters poll of economists released on April 22 confirms that war-driven energy spikes have reignited already-elevated inflation. Gasoline receipts boosted retail sales by 1.7% in March, the largest gain in a year, but analysts noted this was an inflationary mirage as higher fuel costs, not increased volume, accounted for the surge. With oil prices hovering near $112 per barrel due to vessel seizures in the Strait of Hormuz, one-year inflation expectations among households have jumped to 4.8%, the highest since early 2025.
READ MORE: David Einhorn Stock Portfolio: Top 10 Stock Picks.
The impact on the average American consumer has been severe. The University of Michigan’s Surveys of Consumers, reported by Reuters on April 23, shows consumer sentiment plunging 11% this month. Households are expressing substantial concerns over high prices and weaker asset values. This has led to a noticeable flight to value, with shoppers trading down to private-label goods and cutting discretionary spending on vehicles and durable goods. In this environment, defensive stocks have become the primary haven for institutional investors. Consumer staples, healthcare and utilities, as well as telecom sectors are seeing renewed investments. As the US blockade of Iranian ports continues and the UN warns of massive poverty shifts due to fertilizer shortages, the safe-haven rotation into low-beta, high-dividend stocks remains the dominant defensive strategy for the second quarter of 2026.
READ MORE: Mario Gabelli Stock Portfolio: Top 10 Stock Picks.
Our Methodology
For this article, we selected stocks that have solid businesses with recurring revenue streams, reliable dividend payouts, and burgeoning growth pipelines. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2025 database of 1041 elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Best Defensive Stocks to Invest in Now
14. Altria Group, Inc. (NYSE:MO)
The top defensive characteristic of Altria Group, Inc. (NYSE:MO) stock is the nature of the product that the firm sells. Nicotine consumption is historically inelastic, meaning demand does not drop significantly when the economy weakens or prices rise. Altria has consistently offset a 10% annual decline in cigarette volume by raising prices. In 2025, while revenue after excise taxes fell slightly, its adjusted earnings per share actually rose by 4.4% to $5.42, proving its ability to extract profit from a shrinking market. The stock acts more like a high-yield bond than a traditional stock. Altria offers a dividend yield of approximately 6.5% to 6.6%.
Altria Group, Inc. (NYSE:MO) has increased its dividend for 18 consecutive years. In February, it declared a quarterly dividend of $1.06 per share, $4.24 annualized. When including share buybacks, the total shareholder yield exceeded 10% in early 2026, a rarity for a large-cap company. To protect its long-term future, the firm is de-risking its business model by moving away from traditional cigarettes. Shipments of its on! oral nicotine pouches rose 11% in the past year. In March, the company announced a national retail expansion of on! PLUS, aiming to capture more market share from competitors like Zyn. Analysts believe that as the FDA provides more clear pathways for smoke-free products in 2026, the headline risk for Altria is decreasing, making it a more comfortable hold for institutional funds.
